Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Therapeutic potential of cannabinoid medicines.
A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis.
Multiple sclerosis rehabilitation.
Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.
Bilateral optic neuritis after inactivated influenza vaccination.
Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.
Impact on health-related quality of life in multiple sclerosis patients due to a managed care program in Colombia.
Several food items and multiple sclerosis: A case-control study in Ahvaz (Iran).
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females.
CX3CR1 in multiple sclerosis.
MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination.
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.
Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models.
Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life.
[Multiple sclerosis and occupational exposures: results of an explorative study].
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model.
Clinically isolated syndrome manifested as acute vestibular syndrome: Bedside neuro-otological examination and suppression of transient evoked otoacoustic emissions in the differential diagnosis.
Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Failed Concept.
Orthognathic Surgery in a Patient with Multiple Sclerosis.
Sphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015).
Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators.
Macrophage Migration Inhibitory Factor Potentiates Autoimmune-Mediated Neuroinflammation.
Alterations of juxtaparanodal domains in two rodent models of CNS demyelination.
β-Arrestins 1 and 2 are critical regulators of inflammation.
Pages
« first
‹ previous
…
428
429
430
431
432
433
434
435
436
…
next ›
last »